Trials / Recruiting
RecruitingNCT06040489
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of Brasilia · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Randomised clinical trial comparing oral miltefosine associated with pentoxifylline to intravenous liposomal amphotericin b for the treatment of cutaneous and mucosal leishmaniasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Miltefosine 50mg | Oral Miltefosine 50mg bid |
| DRUG | Pentoxifylline 400mg | Oral Pentoxifylline 400mg tid |
| DRUG | Liposomal Amphotericin B | Intravenous 25 to 40mg/kg |
Timeline
- Start date
- 2022-06-22
- Primary completion
- 2024-06-01
- Completion
- 2026-06-01
- First posted
- 2023-09-15
- Last updated
- 2023-09-15
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06040489. Inclusion in this directory is not an endorsement.